HLA‐DRA is associated with Parkinson's disease in Iranian population

The rs3129882, a noncoding variant in HLA‐DR, was found to be associated with Parkinson's disease (PD) using several genome‐wide association studies. The aim of this replication study was to explore the relationship between this variant and PD in Iranian population. Genomic DNA was extracted from peripheral blood samples, and the rs3129882 SNP was genotyped using a PCR‐RFLP method in 520 PD patients and 520 healthy Iranian controls. Significant differences were found in allele frequencies between patients and controls (χ2 = 4.64, P = 0.031). Under additive and dominant models, the association of the SNP with PD risk is significant, where the A allele was observed to be protective. The results suggest that rs3129882 polymorphism may be a risk factor for PD in Iranian. This is the first study reporting such an association in this population. More replication studies are needed to confirm this data.

[1]  A. Brice,et al.  Parkinson's disease: from monogenic forms to genetic susceptibility factors. , 2009, Human molecular genetics.

[2]  Nicholas Eriksson,et al.  Web-Based Genome-Wide Association Study Identifies Two Novel Loci and a Substantial Genetic Component for Parkinson's Disease , 2011, PLoS genetics.

[3]  Eden R Martin,et al.  Meta‐analysis of Parkinson's Disease: Identification of a novel locus, RIT2 , 2012, Annals of neurology.

[4]  D. Dexter,et al.  Parkinson disease: from pathology to molecular disease mechanisms. , 2013, Free radical biology & medicine.

[5]  E. Dietrichs,et al.  Supportive evidence for 11 loci from genome-wide association studies in Parkinson's disease , 2013, Neurobiology of Aging.

[6]  Yusuke Nakamura,et al.  Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease , 2009, Nature Genetics.

[7]  R. Wu,et al.  Reaffirmation of GAK, but not HLA‐DRA, as a Parkinson's disease susceptibility gene in a Taiwanese population , 2013, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[8]  M. Tansey,et al.  Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention , 2007, Experimental Neurology.

[9]  W. Au,et al.  Association of HLA locus variant in Parkinson's disease , 2013, Clinical genetics.

[10]  N. Hattori,et al.  [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease]. , 2004, Rinsho shinkeigaku = Clinical neurology.

[11]  S. Factor,et al.  Evidence for More than One Parkinson's Disease-Associated Variant within the HLA Region , 2011, PloS one.

[12]  S. Factor,et al.  Association of Parkinson disease with structural and regulatory variants in the HLA region. , 2013, American journal of human genetics.

[13]  J. Burgunder,et al.  Association of GWAS loci with PD in China , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[14]  S. Factor,et al.  Identification of a novel Parkinson’s disease locus via stratified genome-wide association study , 2014, BMC Genomics.

[15]  Xavier Estivill,et al.  SNPassoc: an R package to perform whole genome association studies , 2007, Bioinform..

[16]  A. Talebi,et al.  Detection of copy number changes in genes associated with Parkinson's disease in Iranian patients , 2013, Neuroscience Letters.

[17]  J. Nutt,et al.  Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson’s disease , 2010, Nature Genetics.

[18]  H. Deng,et al.  HLA rs3129882 variant in Chinese Han patients with late-onset sporadic Parkinson disease , 2011, Neuroscience Letters.

[19]  M. Barcikowska,et al.  Human leukocyte antigen variation and Parkinson's disease. , 2011, Parkinsonism & related disorders.

[20]  Shirley A. Miller,et al.  A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.

[21]  Mohamad Saad,et al.  Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. , 2011, Human molecular genetics.

[22]  Chuong B. Do,et al.  Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database , 2012, PLoS genetics.

[23]  P. Petramfar,et al.  RIT2, a susceptibility gene for Parkinson's disease in Iranian population , 2014, Neurobiology of Aging.

[24]  Sonja W. Scholz,et al.  Genome-Wide Association Study reveals genetic risk underlying Parkinson’s disease , 2009, Nature Genetics.

[25]  D. Walsh,et al.  Aberrant protein structure and diseases of the brain , 2011, Irish journal of medical science.

[26]  D. Hernandez,et al.  Genome-wide association study confirms extant PD risk loci among the Dutch , 2011, European Journal of Human Genetics.

[27]  Yih-Ru Wu,et al.  Genetic analysis of HLA-DRA region variation in Taiwanese Parkinson's disease. , 2012, Parkinsonism & related disorders.

[28]  Christophe Tzourio,et al.  Association between Parkinson's disease and the HLA‐DRB1 locus , 2012, Movement disorders : official journal of the Movement Disorder Society.